Literature DB >> 9816534

[Basic fibroblast growth factor (b-FGF) in the perimatrix of cholesteatoma].

C Milewski1, A Fedorowski, A C Stan, G F Walter.   

Abstract

UNLABELLED: The growth of a cholesteatoma requires angioneogenesis in the connective tissue of the perimatrix. Angioneogenesis is also needed for wound healing as a host response to tissue injury. Normal wound repair is conducted through a wide number of growth factors. Basic fibroblast growth factor (b-FGF) plays a pivotal role in wound repair. This cytokine exerts its effects through stimulation of a wide range of target cells. B-FGF is chemotactic and mitogenic for fibroblasts, endothelial cells and keratinocytes. In addition, b-FGF can stimulate the production of collagenase and plasminogen activators to enhance fibroblast proliferation and angioneogenesis. Its necessity for normal wound repair has been confirmed by several workers.
METHOD: In order to demonstrate angioneogenesis in the cholesteatoma perimatrix the distribution of b-FGF as the pivotal cytokine of the process was investigated in the perimatrix of 18 cholesteatoma specimens.
RESULTS: B-FGF could be observed in 12 of 18 specimens (66%) in close approximation to histological signs of inflammation and wound healing. Areas with b-FGF also exhibited proliferation of the covering squamous epithelium. Cholesteatoma matrix tissue without inflammation or any sign of wound healing did not express b-FGF (6 of 18).
CONCLUSION: Histological changes and distribution pattern of b-FGF in the perimatrix of cholesteatoma in the present study indicate that the perimatrix cells and substances of the wound healing cascade may play an important role in cholesteatoma development, angiogenesis and growth.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9816534     DOI: 10.1007/s001060050316

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  5 in total

1.  [Angiogenic factors in external auditory canal cholesteatoma-fibroblast cell culture].

Authors:  R Naim; H Sadick; C Bayerl; G Bran; K Hörmann
Journal:  HNO       Date:  2005-11       Impact factor: 1.284

2.  Notes on the microbiology of cholesteatoma: clinical findings and treatment.

Authors:  F Ricciardiello; M Cavaliere; M Mesolella; M Iengo
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-08       Impact factor: 2.124

Review 3.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

Review 4.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

Review 5.  Some considerations about acquired adult and pediatric cholesteatomas.

Authors:  Cristina Dornelles; Sady S da Costa; Luíse Meurer; Cláudia Schweiger
Journal:  Braz J Otorhinolaryngol       Date:  2005-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.